Annual FCF
-$19.81 M
+$5.06 M+20.34%
December 1, 2023
Summary
- As of February 21, 2025, RNTX annual free cash flow is -$19.81 million, with the most recent change of +$5.06 million (+20.34%) on December 1, 2023.
- During the last 3 years, RNTX annual FCF has risen by +$673.00 thousand (+3.29%).
Performance
RNTX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly FCF
-$3.82 M
+$4.57 M+54.48%
September 1, 2024
Summary
- As of February 21, 2025, RNTX quarterly free cash flow is -$3.82 million, with the most recent change of +$4.57 million (+54.48%) on September 1, 2024.
- Over the past year, RNTX quarterly FCF has increased by +$1.45 million (+27.55%).
Performance
RNTX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM FCF
-$27.87 M
-$2.18 M-8.48%
September 1, 2024
Summary
- As of February 21, 2025, RNTX TTM free cash flow is -$27.87 million, with the most recent change of -$2.18 million (-8.48%) on September 1, 2024.
- Over the past year, RNTX TTM FCF has dropped by -$7.45 million (-36.50%).
Performance
RNTX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
RNTX Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +20.3% | +27.6% | -36.5% |
| 3 y3 years | +3.3% | +18.1% | -28.3% |
| 5 y5 years | +38.8% | +45.3% | -13.0% |
RNTX Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +25.5% | +132.9% | +172.1% | +101.6% | at low |
| 5 y | 5-year | at high | +34.4% | +132.9% | +172.1% | +101.6% | at low |
| alltime | all time | +67.8% | +63.3% | +132.9% | +172.1% | +643.6% | +18.6% |
Rein Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$3.82 M(-54.5%) | -$27.87 M(+8.5%) |
| Jun 2024 | - | -$8.39 M(+59.2%) | -$25.69 M(+25.8%) |
| Mar 2024 | - | -$5.27 M(-49.3%) | -$20.42 M(+3.1%) |
| Dec 2023 | -$19.81 M(-20.3%) | -$10.39 M(+533.6%) | -$19.81 M(+43.3%) |
| Sep 2023 | - | -$1.64 M(-47.4%) | -$13.83 M(-27.8%) |
| Jun 2023 | - | -$3.12 M(-33.1%) | -$19.16 M(-11.8%) |
| Mar 2023 | - | -$4.66 M(+5.7%) | -$21.73 M(-12.6%) |
| Dec 2022 | -$24.86 M(+4.0%) | -$4.41 M(-36.8%) | -$24.86 M(-6.9%) |
| Sep 2022 | - | -$6.97 M(+22.6%) | -$26.71 M(-1.1%) |
| Jun 2022 | - | -$5.68 M(-27.1%) | -$27.00 M(+7.4%) |
| Mar 2022 | - | -$7.80 M(+24.7%) | -$25.15 M(+5.2%) |
| Dec 2021 | -$23.91 M(+16.7%) | -$6.25 M(-13.9%) | -$23.91 M(+7.0%) |
| Sep 2021 | - | -$7.26 M(+89.7%) | -$22.34 M(+11.0%) |
| Jun 2021 | - | -$3.83 M(-41.6%) | -$20.12 M(-5.8%) |
| Mar 2021 | - | -$6.56 M(+39.9%) | -$21.37 M(+4.3%) |
| Dec 2020 | -$20.48 M | -$4.69 M(-7.0%) | -$20.48 M(-7.4%) |
| Sep 2020 | - | -$5.04 M(-0.7%) | -$22.11 M(-8.1%) |
| Jun 2020 | - | -$5.08 M(-10.5%) | -$24.05 M(-2.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$5.67 M(-10.3%) | -$24.67 M(-7.3%) |
| Dec 2019 | -$26.63 M(-17.7%) | -$6.32 M(-9.5%) | -$26.63 M(-7.9%) |
| Sep 2019 | - | -$6.98 M(+22.6%) | -$28.90 M(-7.0%) |
| Jun 2019 | - | -$5.70 M(-25.3%) | -$31.07 M(-6.0%) |
| Mar 2019 | - | -$7.63 M(-11.3%) | -$33.04 M(+2.1%) |
| Dec 2018 | -$32.35 M(+56.5%) | -$8.60 M(-6.1%) | -$32.35 M(+9.1%) |
| Sep 2018 | - | -$9.16 M(+19.5%) | -$29.66 M(+15.1%) |
| Jun 2018 | - | -$7.66 M(+10.5%) | -$25.77 M(+19.2%) |
| Mar 2018 | - | -$6.94 M(+17.4%) | -$21.62 M(+4.6%) |
| Dec 2017 | -$20.67 M(+37.7%) | -$5.91 M(+12.2%) | -$20.67 M(+8.8%) |
| Sep 2017 | - | -$5.26 M(+49.8%) | -$19.00 M(+7.6%) |
| Jun 2017 | - | -$3.51 M(-41.3%) | -$17.66 M(+2.4%) |
| Mar 2017 | - | -$5.99 M(+41.5%) | -$17.26 M(+14.9%) |
| Dec 2016 | -$15.01 M(+27.2%) | -$4.23 M(+7.8%) | -$15.01 M(+39.3%) |
| Sep 2016 | - | -$3.93 M(+26.4%) | -$10.78 M(+57.3%) |
| Jun 2016 | - | -$3.11 M(-17.1%) | -$6.86 M(+82.9%) |
| Mar 2016 | - | -$3.75 M | -$3.75 M |
| Dec 2015 | -$11.80 M | - | - |
FAQ
- What is Rein Therapeutics annual free cash flow?
- What is the all time high annual FCF for Rein Therapeutics?
- What is Rein Therapeutics annual FCF year-on-year change?
- What is Rein Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Rein Therapeutics?
- What is Rein Therapeutics quarterly FCF year-on-year change?
- What is Rein Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Rein Therapeutics?
- What is Rein Therapeutics TTM FCF year-on-year change?
What is Rein Therapeutics annual free cash flow?
The current annual FCF of RNTX is -$19.81 M
What is the all time high annual FCF for Rein Therapeutics?
Rein Therapeutics all-time high annual free cash flow is -$11.80 M
What is Rein Therapeutics annual FCF year-on-year change?
Over the past year, RNTX annual free cash flow has changed by +$5.06 M (+20.34%)
What is Rein Therapeutics quarterly free cash flow?
The current quarterly FCF of RNTX is -$3.82 M
What is the all time high quarterly FCF for Rein Therapeutics?
Rein Therapeutics all-time high quarterly free cash flow is -$1.64 M
What is Rein Therapeutics quarterly FCF year-on-year change?
Over the past year, RNTX quarterly free cash flow has changed by +$1.45 M (+27.55%)
What is Rein Therapeutics TTM free cash flow?
The current TTM FCF of RNTX is -$27.87 M
What is the all time high TTM FCF for Rein Therapeutics?
Rein Therapeutics all-time high TTM free cash flow is -$3.75 M
What is Rein Therapeutics TTM FCF year-on-year change?
Over the past year, RNTX TTM free cash flow has changed by -$7.45 M (-36.50%)